US Patent Issued to 3B PHARMACEUTICALS on Sept. 30 for "Compounds comprising a fibroblast activation protein ligand use thereof" (German Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,427,210, issued on Sept. 30, was assigned to 3B PHARMACEUTICALS GMBH (Berlin).

"Compounds comprising a fibroblast activation protein ligand use thereof" was invented by Frank Osterkamp (Berlin), Dirk Zboralski (Berlin), Eberhard Schneider (Brandenburg, Germany), Christian Haase (Berlin), Matthias Paschke (Berlin), Aileen Hohne (Berlin), Jan Ungewiss (Berlin), Christiane Smerling (Berlin), Ulrich Reineke (Berlin) and Anne Bredenbeck (Berlin).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention is related to a compound comprising a cyclic peptide and a chelator, and its use."

The patent was filed on July 8, 2020, under Application No. 17/...